Pharmacokinetics of clarithromycin in the prostate: Implications for the treatment of chronic abacterial prostatitis

Journal of Urology

Volumn 165, Issue 1, 2001, Pages 97-99

  Giannopoulos, Aris ^a   Koratzanis, George ^a   Giamarellos Bourboulis, Evangelos J ^a   Panou, Charalampos ^a   Adamakis, Ioannis ^a   Giamarellou, Helen ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Clarithromycin; Pharmacokinetics; Prostate; Prostatitis

Indexed keywords

CLARITHROMYCIN; CREATININE; UREA;

ADULT; AGAR GEL DIFFUSION; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG TISSUE LEVEL; HUMAN; MALE; MINIMUM INHIBITORY CONCENTRATION; PATHOGENESIS; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROSTATITIS;

EID: 0034749268     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005392-200101000-00024     Document Type: Article

References (17)

1. Chlamydia trachomatis: Probable cause of prostatitis
2. The role of antibiotics in the treatment of chronic prostatitis: A consensus statement
3. Prostatitis
4. Absolute bioavailability of clarithromycin after oral administration in humans
5. Pharmacokinetics and pharmacodynamics of newer macrolides
6. Comparing the means of several groups
7. Simple linear regression in medical research
8. Clarithromycin: Pharmacokinetic and pharmacodynamic interrelationships and dosage regimen
9. Comparative in vitro activity of azithromycin, clarithromycin, erythromycin and lomefloxacin against Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum
10. In vitro evaluation of activities of azithromycin, clarithromycin and sparfloxacin against Chlamydia trachomatis
11. The pH of prostatic fluid: A reappraisal and therapeutic implications
12. Rat model of experimental bacterial prostatitis
13. Epidemiology, etiology, pathophysiology and diagnosis of benign prostatic hyperplasia
14. Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral doses
15. Use of quinolones in treatment of prostatitis and lower urinary tract infections
16. Prostatic tissue levels of ofloxacin
17. A comparative study of the distribution of ofloxacin and ciprofloxacin in prostatic tissues after simultaneous oral ingestion